Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian D Davis

Showing results (171-180 of 282) with videos related to

Pageof 29
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic LesionsJoe H Chang, Daryl Lim Joon, Ian D Davis, et al.
Cancer Immunology, Immunotherapy : CII|June 24, 2011
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™Theo Nicholaou, Weisan Chen, Ian D Davis, et al.
Clinical Genitourinary Cancer|April 13, 2019
Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell CarcinomaRobert J Ellis, Victoria M White, Damien M Bolton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancerDishan H Gunawardana, Russell L Basser, Ian D Davis, et al.
Cancer Causes & Control : CCC|September 26, 2019
Body size and dietary risk factors for aggressive prostate cancer: a case-control studyMikaela Pal, Allison M Hodge, Nathan Papa, et al.
Patient Education and Counseling|January 9, 2022
Attitudes, knowledge and practice behaviours of oncology health care professionals towards lesbian, gay, bisexual, transgender, queer and intersex (LGBTQI) patients and their carers: A mixed-methods studyJane M Ussher, Janette Perz, Kimberley Allison, et al.
Immunotherapy|February 11, 2017
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvantIan D Davis, Juliet Quirk, Leone Morris, et al.
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Urology|January 29, 2014
18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancerLaura S Mertens, M Carmen Mir, Andrew M Scott, et al.
Cancer Immunity|August 21, 2007
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinomaIan D Davis, Zhanqi Liu, Wayne Saunders, et al.
Pageof 29

Showing results (171-180 of 282) with videos related to

Sort By:
Pageof 29
International Journal of Radiation Oncology, Biology, Physics|April 13, 2015
Comparison of [(11)C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic LesionsJoe H Chang, Daryl Lim Joon, Ian D Davis, et al.
Cancer Immunology, Immunotherapy : CII|June 24, 2011
Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™Theo Nicholaou, Weisan Chen, Ian D Davis, et al.
Clinical Genitourinary Cancer|April 13, 2019
Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell CarcinomaRobert J Ellis, Victoria M White, Damien M Bolton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2003
A phase I study of recombinant human leukemia inhibitory factor in patients with advanced cancerDishan H Gunawardana, Russell L Basser, Ian D Davis, et al.
Cancer Causes & Control : CCC|September 26, 2019
Body size and dietary risk factors for aggressive prostate cancer: a case-control studyMikaela Pal, Allison M Hodge, Nathan Papa, et al.
Patient Education and Counseling|January 9, 2022
Attitudes, knowledge and practice behaviours of oncology health care professionals towards lesbian, gay, bisexual, transgender, queer and intersex (LGBTQI) patients and their carers: A mixed-methods studyJane M Ussher, Janette Perz, Kimberley Allison, et al.
Immunotherapy|February 11, 2017
A pilot study of peripheral blood BDCA-1 (CD1c) positive dendritic cells pulsed with NY-ESO-1 ISCOMATRIX™ adjuvantIan D Davis, Juliet Quirk, Leone Morris, et al.
Cancer Research|January 30, 2009
A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine designLisa M Ebert, Yu Chih Liu, Craig S Clements, et al.
Urology|January 29, 2014
18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancerLaura S Mertens, M Carmen Mir, Andrew M Scott, et al.
Cancer Immunity|August 21, 2007
A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinomaIan D Davis, Zhanqi Liu, Wayne Saunders, et al.
Pageof 29